Literature DB >> 11397817

Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method.

R A Weisiger1, J D Ostrow, R K Koehler, C C Webster, P Mukerjee, L Pascolo, C Tiribelli.   

Abstract

Albumin binding is a crucial determinant of bilirubin clearance in health and bilirubin toxicity in certain disease states. However, prior attempts to measure the affinity of albumin for bilirubin have yielded highly variable results, reflecting both differing conditions and the confounding influence of impurities. We therefore have devised a method based on serial ultrafiltration that successively removes impurities in [(14)C]bilirubin until a stable binding affinity is achieved, and then we used it to assess the effect of albumin concentration and buffer composition on binding. The apparent binding affinity of human serum albumin for [(14)C]bilirubin was strongly dependent on assay conditions, falling from (5.09 +/- 0.24) x 10(7) liters/mol at lower albumin concentrations (15 microm) to (0.54 +/- 0.05) x 10(7) liters/mol at higher albumin concentrations (300 microm). To determine whether radioactive impurities were responsible for this change, we estimated impurities in the stock bilirubin using a novel modeling approach and found them to be 0.11-0.13%. Formation of new impurities during the study and their affinity for albumin were also estimated. After correction for impurities, the binding affinity remained heavily dependent on the albumin concentration (range (5.37 +/- 0.26) x 10(7) liters/mol to (0.65 +/- 0.03) x 10(7) liters/mol). Affinities decreased by about half in the presence of chloride (50 mm). Thus, the affinity of human albumin for bilirubin is not constant, but varies with both albumin concentration and buffer composition. Binding may be considerably less avid at physiological albumin concentrations than previously believed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397817     DOI: 10.1074/jbc.M104628200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Bilirubin, a curse and a boon.

Authors:  J D Ostrow; C Tiribelli
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

2.  Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns.

Authors:  Charles E Ahlfors; Hendrik J Vreman; Ronald J Wong; G Jesse Bender; William Oh; Brenda H Morris; David K Stevenson
Journal:  Clin Biochem       Date:  2006-09-29       Impact factor: 3.281

3.  Bilirubin binding with liver cystatin induced structural and functional changes.

Authors:  Mir Faisal Mustafa; Bilqees Bano
Journal:  J Fluoresc       Date:  2014-04-08       Impact factor: 2.217

4.  Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Authors:  Michel Tod; Olivier Mir; Natacha Bancelin; Romain Coriat; Audrey Thomas-Schoemann; Fabrice Taieb; Pascaline Boudou-Rouquette; Stanislas Ropert; Judith Michels; Halim Abbas; Jean Philippe Durand; Alain Dauphin; Michel Vidal; Francois Goldwasser; Benoit Blanchet
Journal:  Pharm Res       Date:  2011-06-21       Impact factor: 4.200

5.  The human multidrug-resistance-associated protein MRP1 mediates ATP-dependent transport of unconjugated bilirubin.

Authors:  Igino Rigato; Lorella Pascolo; Cristina Fernetti; J Donald Ostrow; Claudio Tiribelli
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

6.  Effect of bilirubin on cytochrome c oxidase activity of mitochondria from mouse brain and liver.

Authors:  Safarina G Malik; K Astrid Irwanto; J Donald Ostrow; Claudio Tiribelli
Journal:  BMC Res Notes       Date:  2010-06-09

7.  Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies.

Authors:  Orsolya Dömötör; Christian G Hartinger; Anna K Bytzek; Tamás Kiss; Bernhard K Keppler; Eva A Enyedy
Journal:  J Biol Inorg Chem       Date:  2012-10-18       Impact factor: 3.358

8.  Cross-talk between neurons and astrocytes in response to bilirubin: early beneficial effects.

Authors:  Ana Sofia Falcão; Rui F M Silva; Ana Rita Vaz; Sandra Leitão Silva; Adelaide Fernandes; Dora Brites
Journal:  Neurochem Res       Date:  2013-01-03       Impact factor: 3.996

9.  Thermodynamic considerations in solid adsorption of bound solutes for patient support in liver failure.

Authors:  John F Patzer
Journal:  Artif Organs       Date:  2008-07       Impact factor: 3.094

10.  Unconjugated bilirubin exposure impairs hippocampal long-term synaptic plasticity.

Authors:  Fang-Yu Chang; Cheng-Che Lee; Chiung-Chun Huang; Kuei-Sen Hsu
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.